Amended Statement of Ownership (sc 13g/a)
2019年9月11日 - 4:42AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(RULE 13d - 102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b),
(c) AND
(d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2
(Amendment No. 4)*
Option Care Health, Inc.
(Name of Issuer)
Common Stock, $0.0001 par value per share
(Title of Class of Securities)
68404L102
(CUSIP Number)
August 31, 2019
(Date of Event which Requires Filing of
this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is
filed:
x
Rule 13d-1(b)
¨
Rule 13d-1(c)
¨
Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's initial
filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to
be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject
to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
(Page 1 of 6 Pages)
CUSIP No. 68404L102
1
|
NAME OF REPORTING PERSON
Gilder, Gagnon, Howe & Co. LLC
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) ¨
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
New York
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
6
|
SHARED VOTING POWER
0
|
7
|
SOLE DISPOSITIVE POWER
0
|
8
|
SHARED DISPOSITIVE POWER
15,753,323
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
15,753,323
|
10
|
CHECK IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES ¨
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
2.25%
|
12
|
TYPE OF REPORTING PERSON
BD
|
|
ITEM 1(a).
|
Name of Issuer:
|
Option Care Health, Inc.
|
Item 1(b).
|
Address of Issuer's Principal Executive Offices:
|
3000 Lakeside Dr.,
Suite 300N
Bannockburn, IL 60015
|
Item 2(a).
|
Name of Persons Filing:
|
Gilder, Gagnon, Howe & Co. LLC
|
Item 2(b).
|
Address of Principal Business Office or, if None, Residence:
|
475 10th Avenue
New York, NY 10018
New York
|
Item 2(d).
|
Title of Class of Securities
|
Common Stock
68404L102
ITEM 3.
|
IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:
|
|
(a)
|
x
|
Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
|
|
|
|
|
|
(b)
|
¨
|
Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
(c)
|
¨
|
Insurance
company defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
(d)
|
¨
|
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a–8).
|
|
|
|
|
|
(e)
|
¨
|
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
|
|
|
|
|
|
(f)
|
¨
|
An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
|
|
|
|
|
|
(g)
|
¨
|
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
|
|
|
|
|
|
(h)
|
¨
|
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
|
|
|
|
|
|
(i)
|
¨
|
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a–3);
|
|
(j)
|
¨
|
A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J)
|
|
|
|
|
|
(k)
|
¨
|
Group, in accordance with Rule 13d-1(b)(1)(ii)(K).
|
Provide the following information regarding
the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned: 15,753,323
(b) Percent of class: 2.25%
(c) Number of shares of Common Stock as to which such person has:
|
(i)
|
Sole power to vote or direct the vote: 0
|
|
(ii)
|
Shared
power to vote or direct the vote: 0
|
|
(iii)
|
Sole
power to dispose or direct the disposition: 0
|
|
(iv)
|
Shared
power to dispose or direct the disposition: 15,753,323
|
The shares reported include 15,753,323 shares held
in customer accounts over which partners and/or employees of the Reporting Person have discretionary authority to dispose of or
direct the disposition of the shares.
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
If this statement is being filed
to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent
of the class of securities, check the following x.
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
Not applicable.
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
|
Not applicable.
Item 8.
|
Identification and Classification of Members of the Group.
|
Not applicable.
Item 9.
|
Notice of Dissolution of Group.
|
Not applicable.
By signing below the undersigned certifies that, to
the best of its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business
and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer
of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that
purpose or effect, other than activities solely in connection with a nomination under §240.14a–11.
SIGNATURES
After reasonable inquiry and to the best
of the undersigned’s knowledge and belief, the undersigned certifies that the information set forth in this statement is
true, complete and correct.
Dated: September 10, 2019
|
GILDER, GAGNON, HOWE & CO. LLC
|
|
|
|
|
By:
|
/s/
Laura M. Esposito
|
|
Name:
|
Laura
M. Esposito
|
|
Title:
|
Chief Compliance Officer
|
BioPlus Acquisition (NASDAQ:BIOS)
過去 株価チャート
から 12 2024 まで 1 2025
BioPlus Acquisition (NASDAQ:BIOS)
過去 株価チャート
から 1 2024 まで 1 2025